Publicação
Unified protocol NEURO-VIP-2026: BBB/BSCB permeability optimization via 1 quadrillion (1Q) monte carlo stochastic simulation (Alzheimer's & ALS)
| dc.contributor.author | Viegas, Victor | |
| dc.date.accessioned | 2026-03-06T11:27:48Z | |
| dc.date.available | 2026-03-06T11:27:48Z | |
| dc.date.issued | 2026-03-06 | |
| dc.description.abstract | "This 1 Quadrillion (1Q) iteration study by Victor Viegas (CC 10436868) breaks the 'No Activity' paradox in neurodegenerative clinical trials. It proves that Homocysteine > 14.0 µmol/L induces a chemical sealing of the BBB/BSCB, reducing drug efficacy to < 22%. By implementing the NEURO-VIP-2026 protocol (Methylation Shock + Stem-Clean), neural efficiency (En) is restored to 96.4%. Formulas: En = b0 + (b1 * C_val) - (b2 * V_load) + e. Target Biomarkers: Cystatin C < 0.90 mg/L and Hcy < 9.0 µmol/L." | eng |
| dc.identifier.uri | http://hdl.handle.net/10400.26/62004 | |
| dc.language.iso | eng | |
| dc.peerreviewed | yes | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.title | Unified protocol NEURO-VIP-2026: BBB/BSCB permeability optimization via 1 quadrillion (1Q) monte carlo stochastic simulation (Alzheimer's & ALS) | eng |
| dc.title.alternative | Protocolo unificado NEURO-VIP-2026: otimização da permeabilidade BHE/BME via simulação estocástica monte carlo 1 quadrilhão (1Q) (Alzheimer e ELA) | por |
| dc.type | clinical study | |
| dspace.entity.type | Publication | |
| oaire.version | http://purl.org/coar/version/c_dc82b40f9837b551 |
Ficheiros
Principais
1 - 1 de 1
A carregar...
- Nome:
- Tese_ Victor Viegas_CC10436868_SCIENTIFIC PROJECTION GOE-1Q AD.pdf
- Tamanho:
- 153.26 KB
- Formato:
- Adobe Portable Document Format
Licença
1 - 1 de 1
Miniatura indisponível
- Nome:
- license.txt
- Tamanho:
- 1.85 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: